ECRMC begins new COVID treatment
EL CENTRO, Calif. (KYMA, KECY) - The U.S. Department of Health and Human Services and the El Centro Regional Medical Center began administering monoclonal antibody therapeutic treatments at a temporary COVID-19 infusion center in Imperial County.
Monoclonal antibodies are laboratory-made proteins that mimic the immune system’s ability to fight off harmful antigens such as viruses.
“We’re here for a really important message it’s hope, hope is arriving and we believe that these antibodies and once again high-risk patients will play a very important role but there’s some specifics and one of these specifics is it’s for high-risk patients,” said Michael Anderson, Intensive Care Physician.
The antibodies are administered in the first ten days of diagnosis.
“We believe these therapies are going to help the high risk patients, those that are over 65 and have pr-existing conditions,” added Anderson.
the entire infusion process takes about an hour then they keep the patients to monitor them.
the hospital is preparing to treat 28-30 patients daily with this treatment.
“This is going to be a success, it’s going to help us fight the battle here in a community that has been decimated,” said Dr.Adolphe Edward, Chief executive officer of El Centro Regional Medical Center.